Combination therapy with interferon-alpha 2b and ribavirin for the treatment of relapse patients and non-responders with chronic HCV infection. (Q50585964)
Jump to navigation
Jump to search
scientific article published in March 2001
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Combination therapy with interferon-alpha 2b and ribavirin for the treatment of relapse patients and non-responders with chronic HCV infection. |
scientific article published in March 2001 |
Statements
Combination therapy with interferon-alpha 2b and ribavirin for the treatment of relapse patients and non-responders with chronic HCV infection (English)
B Kallinowski
H Liehr
B Moeller
J G Wechsler
M Wiese